Thalassemia

Program at Children's Hospital of Philadelphia awarded federal grant

Published in Medical Letter on the CDC and FDA, March 30th, 2003

The Children's Hospital of Philadelphia has received a $2.7 million, 5-year grant from the U.S. Centers for Disease Control and Prevention (CDC) for wide-ranging research regarding people suffering from the inherited blood disorder thalassemia.

Because patients with thalassemia require frequent blood transfusions, an important thrust of the grant will be to monitor the nation's blood supply for new infectious agents.

The principal investigator of the grant is Alan R. Cohen, MD, director of Children's Hospital's Thalassemia Program. A pediatric hematologist, Cohen is physician-in-chief at the Children's Hospital of Philadelphia, and a world-renowned...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2003-03-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry